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The aim of the current project was to characterize the luteal vascularity and the plasma concentrations of
progesterone (P4), prolactin (PRL) and 13,14-dihydro-15-keto-PGF2a (PGFM) in mares with luteal disturbances during early and mid-diestrus. In Experiment 1, twenty-one mares were treated with 2 mL of
0.9% NaCl, or 1 mg Dinoprost, or 10 mg Dinoprost on day two after ovulation (Control-D2, 1/10PGF-D2
and PGF-D2 groups, respectively; n ¼ 7 mares/group). In Experiment 2, similar treatments were performed eight days post-ovulation using a different cohort of 21 mares (Control-D8, 1/10PGF-D8 and PGFD8 groups, respectively; n ¼ 7 mares/group). Blood samples were collected hourly and power-Doppler
examinations of the corpus luteum (CL) were performed every 6 h from H0 (moment immediately
before treatment) to H48. Data collection was also done once a day from D0 (day of ovulation) to D20. In
Experiment 1, the PGF-D2 and 1/10PGF-D2 groups had lower increase of plasma concentration of P4 until
H48 and reduced maximum P4 concentrations on D8-D11 than mares from the Control-D2 group.
However, no differences among groups were detected for luteal vascularity during early and middiestrus. In Experiment 2, complete and partial luteolysis were detected in mares from the PGF-D8
and 1/10PGF-D8 groups, respectively. Luteal vascularity and plasma P4 concentrations differed among
Control-D8, PGF-D8 and 1/10PGF-D8 groups on H48. Partially regressed CLs (1/10PGF-D8 group)
generated more Doppler signals than completed regressed CLs (PGF-D8 group) between D10 and D13. In
both experiments, a transient increase in PRL activity was observed in parallel to the PGFM pulse in
mares receiving 1 or 10 mg Dinoprost. The use of prostaglandin on D2 at conventional or 1/10 of the dose
impaired the luteal development in mares. Moreover, the low dose of prostaglandin lead to partial
regression of mature CLs. The blood supply was reduced in partially regressed CLs, but not in CLs undergoing impaired luteogenesis.
Published by Elsevier Inc.
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1. Introduction
The corpus luteum (CL) is a transient endocrine gland mainly
responsible for the synthesis of progesterone (P4), which is
required for the maintenance of normal pregnancy in mammals [1].
The cyclic lifespan of the CL is intimately sustained by a local
angiogenic phenomenon [2]. In mares, luteogenesis requires a
massive sprouting of blood vessels during the ﬁrst three days after
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ovulation [3,4]. Contrariwise, the regression of the CL is followed by
a progressive degradation of its vasculature between days 13 and 16
of the estrus cycle [5].
Colored Doppler ultrasonography has become a readily accessible and valuable technology for reproductive management of females [6,7]. The close relationship between luteal vascularity and
P4 levels during diestrus in mares [8e10] and cows [11,12] suggests
the applicability of Doppler imaging for the analysis of luteal
function. However, recent studies in bovine and equine species
suggest that Doppler ultrasonography is not as accurate to determine luteal disturbances. The volume of bovine CL under partial
regression changes signiﬁcantly in parallel with the levels of P4,
while the luteal vascularity remains unchanged [13]. Moreover, the
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vascularity of the mature CL, but not the synthesis of progesterone,
may be affected by the season in mares [14]. Finally, GnRH and hCG
treatments can stimulate the vascular perfusion of the equine CL
without affecting plasma progesterone concentrations [15].
Therefore, there is a critical need to accurately determine the
applicability of Doppler ultrasonography as a real-time diagnostic
instrument of luteal disorders.
Shortening the estrous cycle by inducing complete luteolysis
with prostaglandin F2a (PGF) or its analogues has been widely used
in equine practice [16]. The effect of PGF on inducing complete
regression of the mature CL is dose-dependent [17,18]. Also, mares
challenged with luteolytic agents during early diestrus undergo
partial regression of the newly formed CL and subsequent resurgence of P4 [19,20]. Therefore, the use of PGF-based protocols may
be useful as a model to investigate luteal disturbances during early
and mid-diestrus in this species.
In mares and heifers [9,21], a greater pulsatility of the PGF
metabolite 13,14-dihydro-15-keto-PGF2alpha (PGFM) occurred
during luteolysis than during preluteolysis and postluteolysis. The
presence of prolactin (PRL) receptors on the equine CL [22] indicates that PRL may directly affect ovarian steroidogenesis and the
luteal structure through the diestrus. Also, the activity of PRL is
markedly increased and synchronized with the PGFM pulses during
complete luteolysis in mares [23]. Therefore, changes on PGF and
PRL rhythmicity may be related to the impaired maturation and
partial regression of the CL.
Since the inadequate levels of P4 may be a potential cause of
infertility and early pregnancy loss in mares [24], the development
of a rapid and on-site diagnostic method for compromised CLs is
critical. Therefore, the main purpose of the present study was to
characterize the endocrine proﬁle and the CL blood-ﬂow of mares
with luteal disturbances during early and mid-diestrus. Our speciﬁc
goals were: a) to describe the changes on plasma concentrations of
P4, PGFM and PRL in mares with impaired luteogenesis or partial
luteolysis, and b) to investigate the efﬁcacy of color Doppler ultrasonography for the real-time diagnosis of luteal abnormalities.

2. Material and methods
2.1. Animals and experimental groups
A total of 42 cycling mixed breed mares were handled in
accordance with the Guide for Care and Use of Agricultural Animals
in Agricultural Research and Teaching. The mares were about 6e15
years of age, weighting 250e380 kg. The animals maintained a high
body condition score (score  7) throughout the experiments [25].
The age of mares was estimated from dental characteristics [26].
The mares were kept under natural light in an open shelter and
outdoor paddock during OctobereDecember at the Reproduction
Center of the School of Veterinary Medicine and Animal Science,
UNESP (22 520 2000 S). All mares were maintained on grass hay,
trace-mineralized salt and water ad libitum. In addition, pelleted
feed was offered twice a day. No macroscopic abnormalities of the
reproductive tract were detected by ultrasound examination. None
of the mares had foaled during the last 5 years preceding the study.
B-mode ultrasonography examination was done once daily to
monitor follicular development. Mares showing a pre-ovulatory
follicle 35 mm of diameter and high endometrial edema [27]
had ovulation induced intravenously with a single dose of 2500
IU of human chorionic gonadotrophin (hCG, Vetecor® 5000 I.U.,
Calier S.A, Spain). Ultrasonography examination of the ovaries was
performed every 6 h from hCG treatment until the observation of
the CL [28]. Only mares with a single ovulation were used for this
study. Day of ovulation was considered D0.
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2.1.1. Experiment 1: impact of prostaglandin challenges on the
development of the CL
Twenty-one mares were used to describe the effect of the
luteolytic and sub-luteolytic doses of PGF on the luteal vascularity
and the plasma concentrations of P4, PGFM and PRL during early
diestrus. A single IM treatment of PGF (Dinoprost tromethamine;
Lutalyse®, Zoetis Inc, Spain) was injected into the deep muscles of
the neck on D2. The mares were arranged in three groups (n ¼ 7
mares/group) according to the PGF dose: 10 mg PGF (luteolytic,
2 mL), 1 mg PGF (sub-luteolytic, 2 mL) and 2 mL of 0.9% NaCl (PGFD2, 1/10 PGF-D2 and Control-D2 groups, respectively).
2.1.2. Experiment 2: effect of a low dose of prostaglandin on the
maintenance of the mature CL
The luteal vascularity and endocrine proﬁle (P4, PGFM and PRL)
of mares with partial or complete artiﬁcially induced or with
spontaneous luteolysis were characterized using 21 additional
mares. A single PGF treatment was done on D8 using the same
doses described for Experiment 1. The mares were assigned into
three groups (n ¼ 7 mares/group): PGF-D8, 1/10 PGF-D8 or ControlD8 groups.
2.2. Data collection
Blood samples were collected every hour and Doppler ultrasound examinations of the CL were performed every 6 h during the
ﬁrst 48 h after treatment. In both experiments, data was also
collected once a day from D0 to D20. Daily data collection was
performed between 1:00e2:00 p.m. The moment immediately
before the treatment was considered H0.
2.2.1. Doppler ultrasonography of the CL
Mares were scanned per rectum using a pulse wavecolor
Doppler ultrasound unit (Sonoace Pico; Medison do Brasil Ltda)
equipped with a linear-array multifrequency transducer (LV59CDn, 5e9 MHz). The brightness and contrast controls of the
monitor and the gain controls of the scanner were kept constant
throughout the experiments [29]. Power-ﬂow function was used to
display blood ﬂow signals in the luteal tissue as previously
described in mares [15,31]. Vascularity of the CL was estimated
subjectively by considering the percentage (0%e100%) of luteal
tissue with color Doppler signals during real-time imaging and
continuous examination with a minimum of 1-min scan. All
Doppler ultrasonography examinations were performed at a constant color-gain setting and a velocity setting of 6 cms1. Luteal
vascularity was estimated by one operator without knowledge of
the treatment. The procedure for estimating the percentage of CL
with blood-ﬂow signals during early and mid-diestrus was previously validated in our laboratory [10].
2.2.2. Blood samples and hormone assays
Blood samples were collected by jugular venipuncture into
heparinized tubes and immediately placed in ice-cold water for
10 min. Subsequently, blood samples were centrifuged (2000g for
10 min at 20  C), and plasma was stored (20  C, 2 cc cryotubes)
until assayed.
Solid-phase radioimmunoassay (RIA) for P4 and PRL was performed in the School of Animal Sciences at Louisiana State University Agricultural Center, Baton Rouge, USA. The plasma samples
were assayed for PGFM by an enzyme-linked immunosorbent assay
(ELISA) in the School of Veterinary Medicine and Animal Science,
UNESP, Botucatu, Brazil.
Concentrations of plasma P4 were measured using a RIA kit
containing antibody-coated tubes and 125I-labeled progesterone
(Coat-a-count progesterone Kit, Diagnostic Product Corporation,
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DPC, Los Angeles, USA). The intra- and inter-assay CV and the assay
sensitivity for P4 were 4.0%, 6.9%, and 0.05 ng mL1, respectively.
Plasma samples were assessed for concentrations of prolactin with
a previously validated RIA developed in our laboratory [30]. The
intra- and inter-assay CV and the assay sensitivity for PRL were 7%,
12%, and 0.2 ng mL1. Plasma PGFM concentrations were measured
using the 13,14-dihydro-15 Prostaglandin F2a EIA kit (Cayman
Chemical; Ann Arbor, USA). The PGFM intra- and inter-assay CV and
the sensitivity for PGF assay were 7.8%, 9.0%, and 28.3 pg mL1,
respectively.
Mares with plasma P4 concentrations <2 ng mL1 within 48 h
after treatment were considered to have had complete regression
of the CL [21]. In experiment 1, impaired luteogenesis was indicated
by a low rate of increase in P4 concentrations on H0-H48 when
compared to Control-D2 group. In experiment 2, partial luteolysis
was characterized by a progressive decrease of the P4 levels
without reaching plasma concentrations <2 ng mL1 on H48 [18].
2.3. Statistical analyses
The continuous data (luteal vascularity, plasma P4, PGFM and
PRL) with repeated measures over time within an experimental
unit were analyzed using the MIXED procedure of SAS (SAS/STAT
version 9.3; SAS Institute Inc., Cary, NC) with models ﬁtting a
Gaussian distribution. Data were tested for normality of residuals,
and non-normally distributed data were transformed before analysis if improvement in residual distribution was observed. To
determine the main effects and interactions, a repeated statement
was used to account for autocorrelation between sequential measurements. Post hoc analyses were conducted using Tukey test. The
level of signiﬁcance was deﬁned at 0.05. Data are presented as the
mean ± standard error of the mean (SEM).
3. Results

Fig. 1. Mean (±SEM) for plasma progesterone concentration (ng mL1) and luteal
vascularity (%) in mares during the ﬁrst 48 h after treatment on D2. The main effect of
treatment (T), hour (H) and the interaction (T:H) are shown. H0 ¼ moment immediately before treatment. * First detected increase (P < 0.05) within each group. a-c Indicates the interval in which the PGF-D2 and Control-D2 groups were different
(P < 0.05). b-c Indicates the interval in which the 1/10PGF-D2 and Control-D2 groups
were different (P < 0.05).

3.1. Experiment 1
A negative effect of prostaglandin on plasma P4 concentrations
was observed during the ﬁrst 48 h after treatment on D2 (P < 0.001;
Fig. 1). P4 progressively increased in the Control-D2 group starting
at H2 (P < 0.001), while no changes were detected in the 1/10PGFD2 and PGF-D2 mares until H16 and H39, respectively (P > 0.2). In
addition, the 1/10PGF-D2 and PGF-D2 groups had lower levels of P4
(P < 0.05) than Control-D2 group, respectively, on H35-H48 and
H5-H48. Mares from the 1/10PGF-D2 and PGF-D2 groups had
similarly low levels of P4 on H48 (9.0 ± 0.5 ng mL1 and
6.3 ± 1.2 ng mL1, respectively; P > 0.3) when compared to ControlD2 group (14.2 ± 0.8 ng mL1; P < 0.05).
Effect of treatment, day and their interaction (P < 0.001) was
detected for plasma P4 concentration from D0 to D20 (Fig. 2). When
compared to the Control-D2 group, the PGF-D2 and 1/10PGF-D2
groups had lower (P < 0.001) levels of P4 on D3-D10 and D7-D10,
respectively. Statistical differences between the PGF-D2 and 1/
10PGF-D2 groups for P4 concentrations within a day were detected
from D3 to D5 (P < 0.001). Also, the maximum plasma P4 concentration was similarly lower in the 1/10PGF-D2 and PGF-D2
groups (11.1 ± 0.6 and 10.3 ± 0.4 ng mL1, respectively; P > 0.3)
than in the Control-D2 group (17.1 ± 0.2 ng mL1; P < 0.05). In
opposite to the observed during the ﬁrst hours after treatment, the
PGF-D2 and 1/10PGF-D2 groups had greater (P < 0.05) levels of P4
than Control-D2 mares on D14-D16 (Fig. 2). The complete luteolysis
(P4 < 2.0 ng mL1) occurred at 14.8 ± 0.5, 16.5 ± 0.3 and 16.6 ± 0.9
days after ovulation in the Control-D2, 1/10PGF-D2 and PGF-D2
groups, respectively.
No differences (P > 0.3) between groups related to vascularity

were found within time during the ﬁrst 48 h after treatment (Fig. 1
and Table 1). Independent of the treatment, luteal vascularity
increased from D0 to D6 (P > 0.001; Fig. 2). Similar to the observed
for plasma P4 concentrations during late diestrus, the luteal
vascularity decreased ﬁrst (P < 0.001) in the Control-D2 group than
in mares from the PGF-D2 and 1/10PGF-D2 groups (Fig. 2). Mares
treated with prostaglandin on D2 showed greater luteal vascularity
than mares from the Control-D2 group between D14 and D16
(P < 0.05).
A transitory increase (P < 0.001) of PGFM was detected immediately after treatment in the PGF-D2 and 1/10PGF-D2 groups
(Fig. 3). Plasma PGFM concentrations were statistically different
among the three groups on H1-H2. Similarly, PGF-D2 mares had
greater levels of PRL than the 1/10GDF-D2 and Control-D2 groups
during the ﬁrst 3 h after treatment (P < 0.003). No differences
(P > 0.1) between 1/10GDF-D2 and Control-D2 were found for PRL
during the experiment (Fig. 3).
3.2. Experiment 2
Effect of treatment, hour and their interaction (P < 0.001) was
detected for plasma P4 concentrations in mares receiving 1 or
10 mg Dinoprost on D8 (Fig. 4). P4 was constantly high in the
Control-D8 group from H0 to H48 (14.5 ± 0.2 ng mL1; P > 0.3).
Decreased levels of P4 were ﬁrst detected (P < 0.0001) on H2 and
H6 in the PGF-D8 and 1/10PGF-D8 groups, respectively. Also, the 1/
10PGF-D8 group showed constantly greater (P < 0.001) levels of P4
than the PGF-D8 group from H27 to H48. At the end of the ﬁrst 48 h
after treatment (Table 2), plasma P4 concentrations
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Fig. 2. Mean (±SEM) for plasma progesterone concentration (ng mL1) and luteal
vascularity (%) from D0 to D20 of mares treated on D2. The main effect of day (D) and
the interaction day:treatment (T:D) are shown. a-c Indicates the interval in which the
PGF-D2 and Control-D2 groups were different (P < 0.05). b-c Indicates the interval in
which the 1/10PGF-D2 and Control-D2 groups were different (P < 0.05). * Control-D2
group was different (P < 0.05) than PGF-D2 and 1/10PGF-D2 groups within the same
hour.

remained > 2 ng mL1 in the Control-D8 and 1/10PGF-D8 groups
(16.0 ± 1.3 and 4.6 ± 1.1 ng mL1, respectively), but not in the PGFD8 group (1.3 ± 0.2 ng mL1).
When compared to the Control-D8 group, mares treated with 1
or 10 mg Dinoprost on D8 had reduced P4 between D9 and D14
(P < 0.01; Fig. 5). Concentrations of P4 also differed (P < 0.04) between the 1/10PGF-D8 and PGF-D8 groups on D10-D13. The day of
complete CL regression (P4 < 2.0 ng mL1) was statistically
different (P < 0.05) among the PGF-D8, 1/10PGF-D8 and Control-D8
groups (9.7 ± 0.2, 13.6 ± 0.8 and 15.6 ± 0.5 days after ovulation,
respectively).
The luteal vascularity was constantly high (79.0 ± 2.1%; P > 0.2)
in the Control-D8 group between H0 and H48 (Fig. 4). Decreased
Table 1
Mean (±SEM) for plasma progesterone concentrations (ng mL1) and luteal vascularity (%) of mares treated with 2 mL NaCl 0.9%, 1 mg Dinoprost tromethamine or
10 mg Dinoprost tromethamine on D2 (Control-D2, 1/10PGF-D2 and PGF-D2 groups,
respectively).
Groups

Progesterone
H0d

Control-D2
1/10PGF-D2
PGF-D2
a, b, c

Luteal vascularity

H48e
aA

3.7 ± 0.0
4.3 ± 0.0aA
3.6 ± 0.0aA

H0d
aB

14.2 ± 0.8
9.0 ± 0.5bB
6.3 ± 1.2cB

H48e
aC

27.1 ± 2.6
23.6 ± 3.4aC
24.2 ± 3.7aC

44.3 ± 6.1aD
52.1 ± 6.7aD
47.1 ± 7.8aD

Progesterone means or luteal vascularity means with different letters within an
same hour are different.
A, B
Progesterone means with different letters within a group are different.
C, D
Luteal vascularity means with different letters within a group are different.
d
Moment immediately before the treatment.
e
Hour 48 after treatment.
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Fig. 3. Mean (±SEM) for plasma concentrations of PGFM and Prolactin (pg mL1) in
mares during the ﬁrst 24 h after treatment on D2. The main effect of treatment (T),
hour (H) and the interaction (T:H) are shown. H0 ¼ moment immediately before
treatment.

values of luteal vascularity were ﬁrst detected 24 h after treatment
in the PGF-D8 and 1/10PGF-D8 (P < 0.001; Fig. 4). Moreover, the
vascularity of the CL differed among the three groups on H48
(P < 0.05; Table 2). Considering the daily examinations, mares from
the 1/10PGF-D8 group also had greater (P < 0.05) luteal vascularity
than the PGF-D8 group until D13 (Fig. 5).
A transitory increase (P < 0.005) of PGFM was detected immediately after the treatment in the PGF-D8 and 1/10PGF-D8 groups
(Fig. 6). Plasma PGFM concentrations were higher in the PGF-D8
group than in the Control-D8 and 1/10PGF-D8 between H1 and
H4 (P < 0.02). When compared to the Control-D8 group, mares
from the PGF-D8 and 1/10PGF-D8 groups had greater PRL levels
(P < 0.05) on H2-H5 and H1-H2, respectively (Fig. 6). In addition,
PRL differed between the PGF-D8 and 1/10PGF-D8 groups on H2H5 (P < 0.004).

4. Discussion
The present study was the ﬁrst to characterize the hemodynamics of equine CLs with compromised development and
incomplete luteolysis. The use of luteolytic and sub-luteolytic doses
of PGF on D2 of the estrous cycle impaired luteogenesis in mares,
whereas the low dose of PGF induced partial regression of the
mature CL without a rebound effect of P4.
It was a long-standing belief that the equine CL should be fully
formed before responding to a luteolytic therapy [31]. However, the
potential refractoriness of the developing CL has been reconsidered
since a delayed increase or a transient decrease of P4 were associated with PGF usage during the periovulatory period in mares
[19,20,32]. The early developing CL appears to be responsive to
exogenous PGF as early as within the ﬁrst 24 h after ovulation
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Fig. 4. Mean (±SEM) for plasma progesterone concentration (ng mL1) and luteal
vascularity (%) in mares during the ﬁrst 48 h after treatment on D8. The main effect of
treatment (T), hour (H) and the interaction (T:H) are shown. H0 ¼ moment immediately before treatment. a,b First detected decrease (P < 0.05) within the PGF-D8 and 1/
10PGF-D8 groups, respectively. * PGF-D8 and 1/10PGF-D8 groups were different
(P < 0.05) within the same hour. Ɵ First detected decrease (P < 0.05) within the PGF-D8
and 1/10PGF-D8 groups. c, d, e Control-D8, PGF-D8 and 1/10PGF-D8 groups were
different (P < 0.05) within the same hour.

Fig. 5. Mean (±SEM) for plasma progesterone concentration (ng mL1) and luteal
vascularity (%) from D0 to D20 of mares treated on D8. The main effect of treatment (T),
day (D) and the interaction (T:D) are shown. D0 ¼ day of ovulation. Experiment 2. a,b,c
Control-D8, PGF-D8 and 1/10PGF-D8 groups were different (P < 0.05) within the same
hour.

[33,34]. Moreover, the repeated administration of PGF over early
diestrus induces a complete antiluteogenic outcome in this species
[35]. In fact, our ﬁndings demonstrated that even a single microdose PGF treatment (1 mg Dinoprost) led to a reduced raise in
plasma P4 concentration throughout the second day after ovulation, while mares receiving the labeled PGF dosage (10 mg Dinoprost) had a prolonged delay in the release of P4 during the
luteogenesis.
Compromised CLs due to PGF-based treatments during the ﬁrst
days after ovulation seemed to rebound to normality by D7-D9
[20,36]. Surprisingly, a succeeding raise of P4 to similar levels seen

Table 2
Mean (±SEM) for plasma progesterone concentrations (ng mL1) and luteal vascularity (%) of mares treated with 2 mL NaCl 0.9%, 1 mg Dinoprost tromethamine or
10 mg Dinoprost tromethamine on D8 (Control-D8, 1/10PGF-D8 and PGF-D8 groups,
respectively).
Groups

Progesterone
H0e

Control-D8
1/10PGF-D8
PGF-D8

Luteal vascularity

H48f
aA

15.7 ± 2.0
11.1 ± 0.8aA
12.4 ± 1.5aA

H0e
aA

16.1 ± 1.3
4.4 ± 1.5bB
1.3 ± 0.2cB

H48f
aC

80.7 ± 3.5
82.5 ± 3.7aC
80.7 ± 2.3aC

79.3 ± 6.0aC
29.2 ± 6.9bD
16.4 ± 3.9cD

a, b, c
Progesterone means or luteal vascularity means with different letters within an
same hour are different.
A, B
Progesterone means with different letters within a group are different.
C, D
Luteal vascularity means with different letters within a group are different.
e
Moment immediately before the treatment.
f
Hour 48 after treatment.

Fig. 6. Mean (±SEM) for plasma concentrations of PGFM and Prolactin (pg mL1) in
mares during the ﬁrst 24 h after treatment on D8. The main effect of treatment (T),
hour (H) and the interaction (T:H) are shown. H0 ¼ moment immediately before
treatment.
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in the control group was not observed in the mares with altered
luteogenesis from Experiment 1. The reduced maximum production of P4 observed in the PGF-D2 and 1/10PGF-D2 mares suggests
a long-lasting impact of exogenous PGF on the luteal function. Even
though the deﬁciency of P4 may be a concern for early embryonic
development [37], pregnancy rates in mares are apparently unaffected by the administration of luteolytic agents during the periovulatory period [36,38]. Also, it is important to note that the P4
levels of both groups that received PGF on D2 remained considerably higher than the minimal needed for pregnancy maintenance
[8].
The initial decrease in P4 followed by continuous
values > 2 ng mL1 until late diestrus showed that a single
administration of 1 mg Dinoprost was effective to induce the
incomplete regression of midcycle CLs (1/10PGF-D8 group; Experiment 2). Our ﬁndings are supported by studies in dairy and beef
cows [13,39,40], which also describe a limited effect of subluteolytic doses of PGF in the CL function. However, in contrast to
the observed in cattle [41], the resurgence of partially regressed CLs
was not detected in mares receiving micro-doses of PGF during
mid-diestrus.
The temporal relationship between plasma PRL concentrations
and PGFM pulses throughout late diestrus is well documented in
mares [23,42]. Nevertheless, this was the ﬁrst report of the doseeffect of exogenous PGF on the PRL proﬁle in mares with newly
formed and midcycle CLs. Independent of the estrous stage, the
synchronic pulses of PGFM and PRL detected immediately after
PGF-treatment were followed by nadir values until H24. Our results
conﬁrmed that the increase of plasma PRL concentrations is a primary effect of PGF and not a result of the variations on P4 production, as previously suggested in mares [42] and cows [43e45].
Apparently, the PRL activity is more likely to have a role in follicular
maturation than in luteolysis [46,47]. The inability to duplicate
sequential pulses of PGFM and PRL reported throughout the
spontaneous luteolysis [23] was a limitation of the current
approach (a single bolus injection of PGF). Nevertheless, our results
encourage further studies with reﬁned experimental designs aiming to simulate the endogenous deliver of PGF associated with
luteal abnormalities.
The equine CL model has a considerable potential for Doppler
studies due to its large dimensions, extensive vascularity and high
PGF sensitivity [7]. However, the subjective analysis of the CL
blood-ﬂow (luteal vascularity) was not sufﬁcient to identify mares
with reduced raise in plasma P4 concentration during early diestrus
(PGF-D2 and 1/10PGF-D2 groups; Experiment 1). The similar luteal
vascularity between mares with normal and delayed luteogenesis
suggests that the development and maintenance of the intraluteal
vessels was not affected by a single PGF treatment on D2. Interestingly, the administration of 10 mg Dinoprost on day three after
ovulation has induced a signiﬁcant structural regression of the
equine CL [19]. In that case, however, the exogenous PGF also
triggered an abrupt decrease in P4 concentrations to nadir values, a
phenomenon not observed in the present study. These distinct
luteolytic effects of 10 mg Dinoprost are related to the age of the CL
at the moment of experimental PGF treatment. The 6 h interval
between the ultrasonography examinations of the ovaries after hCG
treatment assured the earlier detection of the CL. Therefore, all
mares from Experiment 1 received exogenous PGF between 48 and
54 h after ovulation. In the previous study [16], examinations to
detect the ovulation were performed at approximately 24 h intervals and, consequently, the PGF treatments were done 72e96 h
after the ﬁrst visualization of the CL.
Doppler ultrasonography was effective for diagnosing functional
disturbances of midcycle CLs (1/10PGF-D8 group; Experiment 2). In
contrast to the described in heifers [12], an increase in luteal
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vascularity during the ascending portion of the PGFM pulse did not
occur in mares receiving 10 or 1 mg Dinoprost on D8. However, the
vascularity of completely regressed CLs reached nadir values within
the ﬁrst 48 h after treatment, while partially regressed CLs still
generated greater amount of color signals until late diestrus. The
beginning of the complete and partial regression of the mature CL,
as indicated by the decrease in P4 concentrations [31], was initiated
well before the beginning of the decrease in luteal vascularity.
Despite the functional cross-talk between steroidogenic and
vascular cells of the CL [12,48], the slower decrease in luteal
vascularity than in P4 concentrations is compatible with the results
of previous studies of spontaneous and induced luteolysis [8,9,49].
The absence of blood-ﬂow oscillations following PGF challenges
during early diestrus (Experiment 1) and the distinct vascularity
between partially and completely regressed CLs (Experiment 2)
indicate that the luteal vascular changes were stage and PGF-dose
dependent, as previously suggested in cows [50]. Several different
mechanisms are potentially involved in the microvasculature
remodeling of completely and partially regressed CLs. The reduced
luteal blood supply in response to PGF has been associated with
changes in the arterial wall resistance of the ovary [51]. PGF not
only induces the local release of several vasoconstrictor agents
[52,53], but also modulates the expression of vasodilatory and
proangiogenic substances [54e56].
5. Conclusion
Independent the dosage, a single PGF treatment on day two
after ovulation reduced the raise in plasma concentration and the
maximum production of P4 during diestrus. Experimental partially
regressed CLs did not rebounded to normality. Power-Doppler ultrasonography failed to diagnose impaired luteogenesis, but was
effective for the real-time identiﬁcation of incomplete luteolysis
during mid-diestrus. The immediate and transient increase of PRL
was a primary effect of PGF and not a result of the reduced production of P4. Further studies will be needed to clarify the mechanisms that underlie the partial refractoriness of newly formed CLs
and the speciﬁc signaling pathways associated with luteal disturbances in mares.
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